Medicine
Gabapentin 750 mg tablet
Gabapentin 750 mg tablet is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15ºC to 30ºC…
Key facts
- Active ingredient (INN)
- Gabapentin
- Brand
- Sold under the generic name
- Strength
- 750 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 60 tablets and 1 more
- Manufacturer
- Zydus LifesciencesIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15ºC to 30ºC (59ºF to 86ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02BF01 Gabapentin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 September 2025
- Identifiers
- RxCUI 1806380, 1806382, 2634743 +2DailyMed set ID 8c0eeefc-ef5b-49f4-8411-ddbae312ed05, 3cfd04ab-e421-441f-a10e-e4dd1412974dNDC 70771-1917, 68382-356Application ANDA203934
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 68382-356-01 | Zydus LifesciencesIndia | 18 September 2025 |
| 60 tablet in 1 bottle | 68382-356-14 | Zydus LifesciencesIndia | 18 September 2025 |
| 100 tablet in 1 bottle | 70771-1917-1 | Zydus LifesciencesIndia | 18 September 2025 |
| 60 tablet in 1 bottle | 70771-1917-6 | Zydus LifesciencesIndia | 18 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Gabapentin 750 mg tablet.
Other strengths and forms of Gabapentin
Clinical summary
Gabapentin is an anti-epileptic agent indicated for management of postherpetic neuralgia in adults, among other approved uses. It is available as capsules, tablets and oral solution. MedsAcross supplies Gabapentin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GabapentinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Neurontin prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Gabapentin 750 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.